Shares of N4 Pharma PLC (LON: N4P), live biotherapeutics company, surged 11.5% today after stating the total number of ordinary shares with voting rights now stand at 181 million following its latest share placement.
The company’s last announcement in early December of a $2.7 million share placement triggered a 12% drop in its share price as investors seemed surprised by the move.
N4 Pharma issued 25 million shares to raise the money bringing the current total to 181,080,349 ordinary shares each with one voting right.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Today’s announcement was meant to alert investors of the currently outstanding shares they should use to calculate their total holdings in the company according to FCA guidelines.
The company has achieved multiple milestones this year with the latest being an update on its ongoing research project with Nanomerics Limited where it is testing “the stability of different formulations of Nuvec loaded with a well-characterised plasmid DNA.”
The phase I trial indicated that Nuvec formulations that were freeze-dried and stored for 14 days at room temperature or four degrees, “showed no significant drop in in-vitro transfection capability following reconstitution compared to fresh formulations.”
I will be watching this stock in the new year.
N4 Pharma share price
N4 Pharma shares rallied 11.5% to trade at 8.7p having risen from Wednesday’s closing price of 7.8p.
